Influences of Anemia, Kidney Disease, Thyroid Dysfunction, and Liver Disease on the Ratio of Glycated Albumin to Hemoglobin A1c

J Diabetes Sci Technol. 2018 Sep;12(5):1082-1083. doi: 10.1177/1932296818767452. Epub 2018 Apr 5.

Authors

Hiroyasu Miyamoto¹, Xinran Tao², Takuji Kohzuma², Akihiro Ohnishi^{3

4}

Affiliations

¹ 1 Division of Central Laboratory, Jikei University School of Medicine, Tokyo, Japan.
² 2 Clinical Planning & Development Group, Diagnostic Department, Asahi Kasei Pharma Corporation, Tokyo, Japan.
³ 3 Department of Laboratory Medicine, Daisan Hospital, Jikei University School of Medicine, Tokyo, Japan.
⁴ 4 Division of Central Laboratory, Daisan Hospital, Jikei University School of Medicine, Tokyo, Japan.

No abstract available

Keywords: GA/HbA1c ratio; albumin metabolic disorder; glycated albumin; hemoglobin A1c; short erythrocyte life span.

Publication types

Letter

MeSH terms

Aged
Anemia / complications
Biomarkers / blood
Diabetes Complications / blood*
Diabetes Mellitus / blood
Female
Glycated Hemoglobin / analysis*
Glycated Serum Albumin
Glycation End Products, Advanced
Humans
Kidney Diseases / complications
Liver Diseases / complications
Male
Middle Aged
Serum Albumin / analysis*
Thyroid Diseases / complications

Substances

Biomarkers
Glycated Hemoglobin A
Glycation End Products, Advanced
Serum Albumin
hemoglobin A1c protein, human
Glycated Serum Albumin